The schizophrenia syndrome, circa 2024: What we know and how that informs its nature

R Tandon, H Nasrallah, S Akbarian… - Schizophrenia …, 2024 - Elsevier
With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …

Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry

A Etkin, DH Mathalon - JAMA psychiatry, 2024 - jamanetwork.com
Importance Advancing precision psychiatry, where treatments are based on an individual's
biology rather than solely their clinical presentation, requires attention to several key …

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

SW Woods, S Parker, MJ Kerr, BC Walsh… - Early Intervention in …, 2024 - Wiley Online Library
Aim To harmonize two ascertainment and severity rating instruments commonly used for the
clinical high risk syndrome for psychosis (CHR‐P): the Structured Interview for Psychosis …

Normative modeling of brain morphometry in clinical high risk for psychosis

P Allen, H Baldwin, CF Bartholomeusz… - JAMA …, 2024 - jamanetwork.com
Importance The lack of robust neuroanatomical markers of psychosis risk has been
traditionally attributed to heterogeneity. A complementary hypothesis is that variation in …

Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator

MA Worthington, MA Collins, J Addington… - Psychological …, 2024 - cambridge.org
BackgroundClinical implementation of risk calculator models in the clinical high-risk for
psychosis (CHR-P) population has been hindered by heterogeneous risk distributions …

Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for …

CMJ Wannan, B Nelson, J Addington… - Schizophrenia …, 2024 - academic.oup.com
This article describes the rationale, aims, and methodology of the Accelerating Medicines
Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to …

Relations of lifetime perceived stress and basal cortisol with hippocampal volume among healthy adolescents and those at clinical high risk for psychosis: A structural …

K Aberizk, JM Addington, CE Bearden… - Biological …, 2024 - Elsevier
Background Hippocampal volume (HV) is sensitive to environmental influences. Under
normative conditions in humans, HV increases linearly into childhood and asymptotes in …

RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach

MA Worthington, J Addington, CE Bearden… - JAMA …, 2023 - jamanetwork.com
Importance Leveraging the dynamic nature of clinical variables in the clinical high risk for
psychosis (CHR-P) population has the potential to significantly improve the performance of …

Recent updates on predicting conversion in youth at clinical high risk for psychosis

N Caballero, S Machiraju, A Diomino… - Current Psychiatry …, 2023 - Springer
Abstract Purpose of Review This review highlights recent advances in the prediction and
treatment of psychotic conversion. Over the past 25 years, research into the prodromal …

Rethinking the first episode of schizophrenia: identifying convergent mechanisms during development and moving toward prediction

JK Forsyth, CE Bearden - American Journal of Psychiatry, 2023 - Am Psychiatric Assoc
The neurodevelopmental hypothesis of schizophrenia has long suggested that the cardinal
psychotic symptoms that have traditionally defined the disorder, and which most commonly …